VANCOUVER, British Columbia--(BUSINESS WIRE)--The latest advances in innovative technologies designed to streamline the entire stem cell research workflow – from pluripotent cell engineering, culturing, differentiation and characterization to cryopreservation and storage – will be showcased this week during the 12th annual International Society for Stem Cell Research (ISSCR) meeting (Thermo Scientific booth #628, Life Technologies booth #829).
Thermo Fisher Scientific will host a series of customer and thought leader presentations on topics ranging from the use of Sendai virus reprogramming technology for rapid development of human induced pluripotent stem cells (iPSC) for drug development applications, to industrializing pluripotent stem cells and novel platforms for culturing cells in suspension. The speakers will share new innovations being applied in labs at Harvard University, Cedar-Sinai Medical Center and Saitama Medical University.
“Access to leading-edge tools that are designed to seamlessly work in combination with each other is critical for our customers to drive new discoveries,” said Chris Armstrong, Ph.D., vice president and general manager, cell biology, for Thermo Fisher. “We’re proud to offer a deep portfolio of technologies that addresses the entire pluripotent stem cell research continuum to enable novel applications in drug discovery and human disease studies.”
New product innovations at ISSCR this year include:
- When used in combination, the new Lipofectamine 3000 and Epi5 Episomal iPSC Reprogramming Vector reagents demonstrate robust transfection and development of iPSCs and eliminate the need for electroporation, reduce cytotoxicity for more stable, physiologically relevant iPSCs;
- The new PSC Cardiomyocyte Differentiation Kit is designed to deliver rapid differentiation of iPSCs to contracting cardiomyocytes in as few as eight days using a simple three-step process;
- The new Molecular Probes Human Cardiomyocyte Immunocytochemistry and PSC Live Staining Kit is one of nine different characterization kits designed to deliver convenience with all the necessary reagents in a single box to enable superior imaging for fluorescence microscopy-based analysis of live or fixed cells;
- To elevate stem cell differentiation, the new Thermo Scientific Nunclon Sphera non-adherent cell culture surface optimizes three-dimensional spheroid formation designed to allow researchers to grow cells in suspension with consistency and reproducibility; and
- Also on display will include Gibco Essential 8 Medium for growing human iPSCs, updated analysis software for the TaqMan hPSC Scorecard Panel (qPCR-based stem cell characterization), Thermo Scientific Nalgene RapidFlow filtration designed to prevent cell culture contamination, Thermo Scientific cryopreservation consumables, and Fisher BioServices ultra cold-chain logistics for cellular therapeutics clinical trials and commercialization.
Thought Leader Presentations
Join fellow ISSCR attendees for sponsored presentations, including:
Wednesday, June 18, from 8:30 a.m. – 12:30 p.m. (West Ballroom C/D):
Conquering Roadblocks Associated with Stem Cell Differentiation and Disease Modeling:
- Efficient cell specific differentiation systems for iPSC, Mohan C Vemuri, Ph.D., Thermo Fisher
- Supporting three-dimensional culture of stem cells in suspension, Laura E. Jensen, Ph.D., Thermo Fisher
- Exploring standards for industrializing pluripotent stem cells, Hidemasa Kato, MD, Ph.D., Saitama Medical University, Research Center for Genomic Medicine
- Creation of iPSC-based model systems to study Parkinson’s disease, Kurt Vogel, Ph.D., Thermo Fisher
- Physics of failure: How Mother Nature conspires to ruin your clinical trial before you ship your first dose, Dan H. O’Donnell, Fisher BioServices
Thursday, June 19, from 11:30 a.m. – 12:30 p.m. (West
ISSCR Innovation Showcase
- Reprogramming somatic cells using the Sendai virus technology, Laurence Daheron, Ph.D., manager of the iPS Core, Harvard University, will discuss the advantages of using the Life Technologies Cytotune-iPS 2.0 Reprogramming Kit
- From bland to grand: iPSC technology and its applications, Dhruv Sareen, Ph.D., director of the iPSC Core at Cedars-Sinai Medical Center, will discuss how human iPSC technology will help drive high-scale development of physiologically-relevant human cells for drug discovery applications
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our four premier brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.